PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Oral administration of watermelon seed oil (WMSO) in rats significantly decreased serum cholesterol, triglycerides, LDL, ALT, and MDA, while enhancing HDL, VLDL, SOD, and CAT levels [PMID:34002399].
A positive oral glucose-lowering effect was observed following the administration of watermelon seed oil in rats [PMID:34002399].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 34002399 (2021) — Evaluation of nutritional composition of Citrullus lanatus Linn. (watermelon) seed and biochemical assessment of the seed oil in rats. · Journal of food biochemistry
- 2.PMID: 39795237 (2025) — Preliminary Data of the Nutritive, Antioxidative, and Functional Properties of Watermelon (Citrullus lanatus L.) Flour and Seed Protein Concentrate. · Molecules (Basel, Switzerland)
- 3.PMID: 33682546 (2022) — Toxicity assessment of watermelon seed supplemented diet in rats. · Drug and chemical toxicology
- 4.PMID: 15220396 (2004) — Inheritance of egusi seed type in watermelon. · The Journal of heredity